₹245.03
−4.13%NSE close, 16 Nov 2026
+65.62%
Park Medi World is a small cap company in the Healthcare sector, listed on NSE under the symbol PARKHOSPS. At ₹245.03 a share, the market values the whole company at ₹10,584 crore.
In FY26, it reported sales of ₹1,679 crore and a net profit of ₹258 crore, an operating margin of 26.5%.
The market values the company at 41.3 times its profit over the last twelve months and 4.90 times its book value; its return on equity is 11.9% and its borrowings are 0.21 times its equity.
Promoters hold 82.90% of the shares. Foreign institutions hold 0.88%, and domestic institutions, mutual funds among them, 8.24%.
Companies of a similar size in the same sector include Concord Biotech, Metropolis Healthcare, Akums Drugs and Pharmaceuticals and Viyash Scientific.
₹ crore. Consolidated figures.
The same sector (Healthcare), nearest in size.
| Company | Price | Market cap | P/E | ROE | Sales growth | 1Y |
|---|---|---|---|---|---|---|
| Park Medi World | ₹245.03 | ₹10,584 cr | 41.3 | 11.9% | n/a | n/a |
| Concord Biotech | ₹581.00 | ₹12,156 cr | 43.0 | 13.6% | +25.10% | −17.67% |
| Metropolis Healthcare | ₹574.15 | ₹11,907 cr | 53.1 | 13.7% | +15.80% | +14.50% |
| Akums Drugs and Pharmaceuticals | ₹722.20 | ₹11,367 cr | 31.2 | 10.4% | +31.90% | +56.88% |
| Viyash Scientific | ₹236.38 | ₹10,439 cr | 44.9 |
Cancellation of Schedule of meet
Link of Audio Recording for the Earnings Conference Call held today i.e. November 14, 2026
Monitoring Agency Report for the Quarter ended September 30, 2026
| 27.7% |
| 26.5% |
| 19.9% |
| Other income | 9.1 | 7.5 | 7.7 | 9.6 |
|---|
| Interest | 15.0 | 14.0 | 9.8 | 14.1 |
|---|
| Depreciation | 15.3 | 17.5 | 18.8 | 20.9 |
|---|
| Profit before tax | 78.3 | 103 | 105 | 76.4 |
|---|
| Tax | 25.4 | 26.6 | 16.5 | 22.0 |
|---|
| Net profit | 50.8 | 70.9 | 82.5 | 52.2 |
|---|
| EPS (₹) | 1.35 | 1.78 | 2.05 | 1.26 |
|---|
₹ crore, financial years to March.
| Line | FY26 |
|---|---|
| Sales | 1,679 |
| Expenses | 1,235 |
| Operating profit | 444 |
| Operating margin | 26.5% |
| Other income | 31.6 |
| Interest | 58.9 |
| Depreciation | 62.5 |
| Profit before tax | 355 |
| Tax | 81.0 |
| Net profit | 258 |
| EPS (₹) | 6.87 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY26 | 6M to Sep 2026 |
|---|---|---|
| From operations | 329 | −200 |
| From investing | −333 | −157 |
| From financing | 121 | 194 |
| Spent on fixed assets | −120 | −59.9 |
| Free cash flow | 209 | −260 |
Margins, returns, debt, tax and cash.
| Line | FY26 |
|---|---|
| Net margin | 15.4% |
| Operating margin | 26.5% |
| Return on equity | 12.8% |
| Return on capital employed | 18.4% |
| Return on assets | 9.2% |
| Debt to equity | 0.11 |
| Interest coverage | 7.00 |
| Debt to assets | 0.08 |
| Current ratio | 2.06 |
| Quick ratio | 2.05 |
| Cash ratio | 0.45 |
| Asset turnover | 0.60 |
| Fixed asset turnover | 2.13 |
| Inventory turnover | 102.00 |
| Receivables turnover | 2.80 |
| Gross margin | 82.4% |
| Cash from operations to profit | 127.0% |
| Effective tax rate | 22.9% |
| 7.3% |
| +133.00% |
| +9.21% |
| Yatharth Hospital & Trauma Care Services | ₹1,069.05 | ₹10,301 cr | 54.9 | 10.0% | +54.40% | +34.65% |
|---|
| Blue Jet Healthcare | ₹512.95 | ₹9,709 cr | 34.0 | 12.4% | +127.10% | −8.67% |
|---|
| Procter & Gamble Health | ₹5,595.50 | ₹9,288 cr | 24.5 | 57.7% | +17.70% | −6.69% |
|---|
| Strides Pharma Science | ₹986.10 | ₹9,089 cr | 14.7 | 18.1% | +17.10% | +2.78% |
|---|
Earnings Release for Q2 & H1 FY'27 Unaudited results
The financial results for the period ended September 30, 2026.
Schedule of meet
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Schedule of meet
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
A copy Srutinizers report of Annual General Meeting held on September 22, 2026. Further, the company has informed the Exchange regarding voting results.
Proceedings of 15th Annual General Meeting held on September 22, 2026
Park Group of Hospitals Wins Three Honours at Healthcare Pioneers of Delhi 2026